Patents by Inventor Noriyuki Kouda
Noriyuki Kouda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230017155Abstract: Provided is a heat shock protein expression-inducing agent, more specifically, a heat shock protein expression-inducing agent comprising a compound represented by formula (I): wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof.Type: ApplicationFiled: September 9, 2022Publication date: January 19, 2023Applicants: Amino Up Co., Ltd., Otsuka Pharmaceutical Co., Ltd.Inventors: Kazunori GOTO, Jun NAKAHIGASHI, Atsuya SATO, Yosuke HIRAYAMA, Moeri HORIKOSHI, Noriyuki KOUDA, Syoichiro INOUE, Ikutaro SATO, Manami KATO
-
Publication number: 20220387464Abstract: The present invention further provides a composition for inhibiting purine body absorption, a composition for inhibiting purine nucleotide metabolism, a composition for inhibiting phosphatase, a composition for inhibiting uric acid level elevation, a composition for improving blood pressure, a composition for improving blood glucose level, a composition for improving liver function, a composition for controlling serum iron level, or a composition for promoting calcium absorption, comprising an inositol phosphate or a salt thereof. The present invention further provides a composition comprising an inositol phosphate or a salt thereof, wherein the taste thereof is improved by adding thereto a predetermined amount of calcium lactate.Type: ApplicationFiled: August 16, 2022Publication date: December 8, 2022Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Takeshi IKENAGA, Hiroki NOGUCHI, Chieko KOHASHI, Noriyuki KOUDA, Ayako TAKAISHI
-
Patent number: 11478473Abstract: The present invention provides a heat shock protein expression-inducing agent, more specifically, a heat shock protein expression-inducing agent comprising a compound represented by formula (I): wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof.Type: GrantFiled: April 3, 2020Date of Patent: October 25, 2022Assignees: Amino Up Co., Ltd., Otsuka Pharmaceutical Co., Ltd.Inventors: Kazunori Goto, Jun Nakahigashi, Atsuya Sato, Yosuke Hirayama, Moeri Horikoshi, Noriyuki Kouda, Syoichiro Inoue, Ikutaro Sato, Manami Kato
-
Patent number: 11446317Abstract: The present invention further provides a composition for inhibiting purine body absorption, a composition for inhibiting purine nucleotide metabolism, a composition for inhibiting phosphatase, a composition for inhibiting uric acid level elevation, a composition for improving blood pressure, a composition for improving blood glucose level, a composition for improving liver function, a composition for controlling serum iron level, or a composition for promoting calcium absorption, comprising an inositol phosphate or a salt thereof. The present invention further provides a composition comprising an inositol phosphate or a salt thereof, wherein the taste thereof is improved by adding thereto a predetermined amount of calcium lactate.Type: GrantFiled: October 26, 2017Date of Patent: September 20, 2022Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Takeshi Ikenaga, Hiroki Noguchi, Chieko Kohashi, Noriyuki Kouda, Ayako Takaishi
-
Publication number: 20210177876Abstract: The present invention further provides a composition for inhibiting purine body absorption, a composition for inhibiting purine nucleotide metabolism, a composition for inhibiting phosphatase, a composition for inhibiting uric acid level elevation, a composition for improving blood pressure, a composition for improving blood glucose level, a composition for improving liver function, a composition for controlling serum iron level, or a composition for promoting calcium absorption, comprising an inositol phosphate or a salt thereof. The present invention further provides a composition comprising an inositol phosphate or a salt thereof, wherein the taste thereof is improved by adding thereto a predetermined amount of calcium lactate.Type: ApplicationFiled: October 26, 2017Publication date: June 17, 2021Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Takeshi IKENAGA, Hiroki NOGUCHI, Chieko KOHASHI, Noriyuki KOUDA, Ayako TAKAISHI
-
Publication number: 20200246335Abstract: The present invention provides a heat shock protein expression-inducing agent, more specifically, a heat shock protein expression-inducing agent comprising a compound represented by formula (I): wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof.Type: ApplicationFiled: April 3, 2020Publication date: August 6, 2020Applicants: AMINO UP CHEMICAL CO., LTD., OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Kazunori GOTO, Jun NAKAHIGASHI, Atsuya SATO, Yosuke HIRAYAMA, Moeri HORIKOSHI, Noriyuki KOUDA, Syoichiro INOUE, Ikutaro SATO, Manami KATO
-
Patent number: 10369177Abstract: [Object] An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent. [Method for Achieving the Object] A QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent containing Lactobacillus ONRICb0240 (FERM BP-10065).Type: GrantFiled: April 17, 2017Date of Patent: August 6, 2019Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Mina Tsubouchi, Takao Saito, Masamichi Toba, Noriyuki Kouda, Shoji Shinkai
-
Publication number: 20190201395Abstract: The present invention provides a heat shock protein expression-inducing agent, more specifically, a heat shock protein expression-inducing agent comprising a compound represented by formula (I): wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof.Type: ApplicationFiled: May 26, 2017Publication date: July 4, 2019Applicants: AMINO UP CHEMICAL CO., LTD., OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Kazunori GOTO, Jun NAKAHIGASHI, Atsuya SATO, Yosuke HIRAYAMA, Moeri HORIKOSHI, Noriyuki KOUDA, Syoichiro INOUE, Ikutaro SATO, Manami KATO
-
Publication number: 20190055613Abstract: A major object of the present invention is to provide an effective means for promoting polyamine synthesis in an organism (in particular, in humans). Lactobacillus paracasei having polyamine production promoting activity in an organism.Type: ApplicationFiled: March 14, 2018Publication date: February 21, 2019Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Takeshi IKENAGA, Tsuneyuki NODA, Yoshito TAJIRI, Hiroki NOGUCHI, Atsushi UEDA, Noriyuki KOUDA
-
Publication number: 20170216379Abstract: [Object] An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent. [Method for Achieving the Object] A QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent containing Lactobacillus ONRICb0240 (FERM BP-10065).Type: ApplicationFiled: April 17, 2017Publication date: August 3, 2017Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Mina TSUBOUCHI, Takao SAITO, Masamichi TOBA, Noriyuki KOUDA, Shoji SHINKAI
-
Publication number: 20170137902Abstract: A major object of the present invention is to provide an effective means for promoting polyamine synthesis in an organism (in particular, in humans). Lactobacillus paracasei having polyamine production promoting activity in an organism.Type: ApplicationFiled: March 23, 2015Publication date: May 18, 2017Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Takeshi IKENAGA, Tsuneyuki NODA, Yoshito TAJIRI, Hiroki NOGUCHI, Atsushi UEDA, Noriyuki KOUDA
-
Patent number: 9623054Abstract: An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent. [Method for Achieving the Object] A QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent containing Lactobacillus ONRICb0240 (FERM BP-10065).Type: GrantFiled: March 28, 2012Date of Patent: April 18, 2017Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Mina Tsubouchi, Takao Saito, Masamichi Toba, Noriyuki Kouda, Shoji Shinkai
-
Publication number: 20140017217Abstract: An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent. Method for Achieving the Object A QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent containing Lactobacillus ONRICb0240 (FERM BP-10065).Type: ApplicationFiled: March 28, 2012Publication date: January 16, 2014Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Mina Tsubouchi, Takao Saito, Masamichi Toba, Noriyuki Kouda, Shoji Shinkai